IE 11 is not supported. For an optimal experience visit our site on another browser.

Once free, drug for rare disease now being sold for $375K a year


Thanks to a law designed to encourage drug development for rare diseases, Catalyst Pharmaceuticals can now sell the treatment exclusively for seven years -- and has set the price for it at $375,000 on average, when it used to be given to patients for free by a smaller drug company.